Aimei Health Technology Co., Ltd Unit financials
$13.09+0.69%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q4 '24 Dec 31 | Q3 '24 Sep 30 | Q2 '24 Jun 30 | Q1 '24 Mar 31 | Q4 '23 Dec 31 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | — |
| Gross margin | — | — | — | — | — | — | — | — | — | — | — |
| Operating income | -$192.3K | -$62.0K | -$250.6K | -$130.2K | -$41.6K | -$413.4K | -$402.0K | -$200.0K | -$309.1K | -$153.6K | — |
| Net income | -$83.1K | $45.4K | $98.1K | $352.0K | $425.0K | $184.7K | $444.1K | $743.5K | $465.6K | $755.5K | — |
| Net margin | — | — | — | — | — | — | — | — | — | — | — |
| Diluted EPS | $-0.03 | $0.01 | $0.02 | $0.06 | $0.07 | $0.03 | $0.04 | $0.08 | $0.07 | $0.08 | — |
| EBITDA | -$192.3K | -$62.0K | -$250.6K | -$130.2K | -$41.6K | -$413.4K | -$402.0K | -$200.0K | -$309.1K | -$153.6K | $0.00 |
| Operating cash flow | -$156.9K | -$74.6K | -$43.2K | -$96.1K | -$201.8K | -$224.0K | -$195.1K | -$53.9K | -$256.2K | -$167.0K | — |
| Free cash flow | -$156.9K | -$74.6K | -$43.2K | -$96.1K | -$201.8K | -$224.0K | -$195.1K | -$53.9K | -$256.2K | -$167.0K | — |
| Diluted shares | 3.2M | 3.2M | 5.2M | 6.1M | 6.1M | 7.3M | 11.2M | 9.0M | 6.9M | 9.0M | 2.2M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $1.5K | $18.5K | $2.9K | $3.0K | $2.1K | $7.3K |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $2.2M | $2.1M | $2.0M | $1.7M | $1.2M | $755.4K |
| Total assets | $12.5M | $12.3M | $12.1M | $45.5M | $44.6M | $43.6M |
| Total liabilities | $4.5M | $4.2M | $4.1M | $3.5M | $2.9M | $2.4M |
| Shareholders' equity | -$4.5M | -$4.2M | -$4.1M | -$3.4M | -$2.9M | -$2.4M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology